Cargando…
Do Mutations Turn p53 into an Oncogene?
The key role of p53 as a tumor suppressor became clear when it was realized that this gene is mutated in 50% of human sporadic cancers, and germline mutations expose carriers to cancer risk throughout their lifespan. Mutations in this gene not only abolish the tumor suppressive functions of p53, but...
Autores principales: | Pitolli, Consuelo, Wang, Ying, Mancini, Mara, Shi, Yufang, Melino, Gerry, Amelio, Ivano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940991/ https://www.ncbi.nlm.nih.gov/pubmed/31835684 http://dx.doi.org/10.3390/ijms20246241 |
Ejemplares similares
-
p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms
por: Pitolli, Consuelo, et al.
Publicado: (2019) -
Commensal microbes and p53 in cancer progression
por: Celardo, Ivana, et al.
Publicado: (2020) -
Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020) -
Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021) -
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer
por: Zampieri, Carlotta, et al.
Publicado: (2022)